role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS

Safai, 1992, Malignant neoplasms associated with human immunodeficiency virus infection, Ca Cancer J Clin, 42, 74, 10.3322/canjclin.42.2.74 Haverkos, 1993, Epidemiology of AIDSrelated Kaposi's sarcoma (KS): an update, 9, 938 Beral, 1990, Kaposi's sarcoma among persons with AIDS: a sexually transmitted disease?, Lancet, 335, 123, 10.1016/0140-6736(90)90001-L Jacobson, 1990, Incidence of Kaposi's sarcoma in a cohort of homosexual men infected with human immunodeficiency virus type I, J Acquir Immune Defic Syndr, 3, S24 Reichert, 1993, Epidemic orofacial Kaposi's sarcoma (eKS)—report of 124 cases, Oral Oncology, Eur J Cancer, 29B, 187, 10.1016/0964-1955(93)90021-6 Reichert, 1987, AIDS and the oral cavity. The HIV infection: virology, etiology, origin, immunology, precautions and clinical observations in 110 patients, Int J Oral Maxillofac Surg, 6, 129, 10.1016/S0901-5027(87)80122-4 Schiodt, 1986, AIDS and the oral cavity. Epidemiology and clinical oral manifestations of human immune deficiency virus infection: a review, Int J Oral Maxillofac Surg, 15, 857 Nichols, 1993, Treating Kaposi's lesions in the HIV-infected patient, J Am Dent Assoc, 124, 78, 10.14219/jada.archive.1993.0231 Ficarra, 1988, Kaposi's sarcoma of the oral cavity: a study of 134 patients and review of pathogenesis, epidemiology, clinical aspects and treatment, Oral Surg Oral Med Oral Pathol, 66, 543, 10.1016/0030-4220(88)90373-8 Petit, 1986, Progressive changes of Kaposi's sarcoma of the gingiva and palate, J Periodontol, 57, 159, 10.1902/jop.1986.57.3.159 Langford, 1991, Primary intraosseous AIDS associated Kaposi's sarcoma. Report of two cases with initial jaw involvement, Int J Oral Maxillofac Surg, 20, 366, 10.1016/S0901-5027(05)80268-1 Epstein, 1993, Treatment of oral Kaposi's sarcoma with intralesional vinblastine, Cancer, 71, 1722, 10.1002/1097-0142(19930301)71:5<1722::AID-CNCR2820710503>3.0.CO;2-0 Epstein, 1989, Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of efficacy of intralesional vinblastine, Cancer, 64, 2424, 10.1002/1097-0142(19891215)64:12<2424::AID-CNCR2820641205>3.0.CO;2-X Epstein, 1989, Intralesional vinblastine for oral Kaposi's sarcoma in HIV infection, Lancet, 867, 1100, 10.1016/S0140-6736(89)91114-8 Cooper, 1987, Toxicity of oral radiotherapy in patients with acquired immunodeficiency syndrome, Arch Otolaryngol Head Neck Surg, 113, 327, 10.1001/archotol.1987.01860030103019 Hill, 1987, The role of radiotherapy for epidemic Kaposi's sarcoma, 14, 19 Chak, 1988, Radiation therapy for acquired immunodeficiency syndrome-related Kaposi's sarcoma, J Clin Oncol, 6, 863, 10.1200/JCO.1988.6.5.863 Gill, 1991, Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial, Am J Med, 90, 427, 10.1016/0002-9343(91)80081-V Gill, 1990, Treatment of advanced Kaposi's sarcoma using combination chemotherapy, Am J Clin Oncol, 13, 315, 10.1097/00000421-199008000-00010 Rarick, 1990, Treatment of epidemic Kaposi's sarcoma with combination chemotherapy and zidovudine, Ann Oncol, 1, 147, 10.1093/oxfordjournals.annonc.a057693 Lucartorto, 1993, Treatment of oral Kaposi's sarcoma with a sclerosing agent in AIDS patients, Oral Surg Oral Med Oral Pathol, 75, 192, 10.1016/0030-4220(93)90093-J Epslin, 1991, V-related neoplastic disease: 1991, AIDS, 5, S203